Cargando…
Hemovigilance Program–India
A centralized hemovigilance program to assure patient safety and to promote public health has been launched for the first time in India on Dec 10, 2012 in 60 medical colleges in the first phase along with a well-structured program for monitoring adverse reactions associated with blood transfusion an...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613669/ https://www.ncbi.nlm.nih.gov/pubmed/23559771 http://dx.doi.org/10.4103/0973-6247.106744 |
_version_ | 1782264760847302656 |
---|---|
author | Bisht, Akanksha Singh, Surinder Marwaha, Neelam |
author_facet | Bisht, Akanksha Singh, Surinder Marwaha, Neelam |
author_sort | Bisht, Akanksha |
collection | PubMed |
description | A centralized hemovigilance program to assure patient safety and to promote public health has been launched for the first time in India on Dec 10, 2012 in 60 medical colleges in the first phase along with a well-structured program for monitoring adverse reactions associated with blood transfusion and blood product administration. National Institute of Biologicals (NIB) will be the National Coordinating Centre for Hemovigilance. This program will be implemented under overall ambit of Pharmacovigilance Program of India (PvPI), which is being coordinated by Indian Pharmacopoeia Commission (IPC). All medical colleges of the country will be enrolled in this program by the year 2016 in order to have a National Centre of Excellence for Hemovigilance at NIB, which will act as a global knowledge platform. |
format | Online Article Text |
id | pubmed-3613669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36136692013-04-04 Hemovigilance Program–India Bisht, Akanksha Singh, Surinder Marwaha, Neelam Asian J Transfus Sci Brief Communication A centralized hemovigilance program to assure patient safety and to promote public health has been launched for the first time in India on Dec 10, 2012 in 60 medical colleges in the first phase along with a well-structured program for monitoring adverse reactions associated with blood transfusion and blood product administration. National Institute of Biologicals (NIB) will be the National Coordinating Centre for Hemovigilance. This program will be implemented under overall ambit of Pharmacovigilance Program of India (PvPI), which is being coordinated by Indian Pharmacopoeia Commission (IPC). All medical colleges of the country will be enrolled in this program by the year 2016 in order to have a National Centre of Excellence for Hemovigilance at NIB, which will act as a global knowledge platform. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3613669/ /pubmed/23559771 http://dx.doi.org/10.4103/0973-6247.106744 Text en Copyright: © Asian Journal of Transfusion Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Bisht, Akanksha Singh, Surinder Marwaha, Neelam Hemovigilance Program–India |
title | Hemovigilance Program–India |
title_full | Hemovigilance Program–India |
title_fullStr | Hemovigilance Program–India |
title_full_unstemmed | Hemovigilance Program–India |
title_short | Hemovigilance Program–India |
title_sort | hemovigilance program–india |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613669/ https://www.ncbi.nlm.nih.gov/pubmed/23559771 http://dx.doi.org/10.4103/0973-6247.106744 |
work_keys_str_mv | AT bishtakanksha hemovigilanceprogramindia AT singhsurinder hemovigilanceprogramindia AT marwahaneelam hemovigilanceprogramindia |